Agnieszka Los-Stegienta

Dr. Agnieszka Los-Stegienta

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Microvascular Research
Verified
Journal Article
Closed access
JKJoanna Katarzynska
Joanna Katarzynska
ABAnna Borkowska
Anna Borkowska
Przemyslaw CzajkowskiPrzemyslaw Czajkowski
Przemyslaw Czajkowski
ALAgnieszka Los-Stegienta
Agnieszka Los-Stegienta
LSLukasz Szczerbinski
Lukasz Szczerbinski
JGJerzy Gebicki
Jerzy Gebicki

19 December 2019 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
PDF file
JKJoanna Katarzynska
Joanna Katarzynska
ABAnna Borkowska
Anna Borkowska
ALAgnieszka Los-Stegienta
Agnieszka Los-Stegienta
AMAndrzej Marcinek
Andrzej Marcinek
KCKatarzyna Cypryk
Katarzyna Cypryk
JGJerzy Gebicki
Jerzy Gebicki

1 April 2021 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
ALAgnieszka Los-Stegienta
Agnieszka Los-Stegienta
JKJoanna Beata Katarzyńska
Joanna Beata Katarzyńska
ABAnna Borkowska
Anna Borkowska
AMAndrzej Marcinek
Andrzej Marcinek
KCKatarzyna Cypryk
Katarzyna Cypryk
JGJerzy Gebicki
Jerzy Gebicki
Purpose: Diabetic foot ulceration is a chronic complication characterized by impaired wound healing. There is a great demand for a diagnostic tool that is able to monitor and predict wound healing. Patients and Methods: Oscillations in the microcirculation, known as flowmotion, can be monitored very distinctly and precisely using the Flow Mediated Skin Fluorescence (FMSF) technique. The flowmotion response to hypoxia was measured quantitatively in 42 patients with diabetic foot ulcers. Results: The flowmotion response to hypoxia parameters FM(R) and HS were used to differentiate the diabetic foot ulcers and correlate them with clinical status. In some cases, FMSF measurements were continued over the period of a year in order to monitor disease progress. The clinical status of the quarter of patients with the highest HS values (group A, HS = 50.2± 18.3) was compared to the quarter with the lowest HS values (group B, HS = 4.3± 1.7). The patients in the group B were identified as having low prognosis for healing and were characterized by higher incidences of hypertension, hyperlipidemia, prevalent CVD, neuropathy and nephropathy. Conclusion: Impaired flowmotion responses to hypoxia induced by transient ischemia can be used for differentiation of diabetic foot ulcers and identification of cases with low prognosis for healing.

25 September 2024 in Biosensors
Verified
Journal Article
Open access
PDF file
AMAndrzej Marcinek
Andrzej Marcinek
JKJoanna Beata Katarzyńska
Joanna Beata Katarzyńska
KCKatarzyna Cypryk
Katarzyna Cypryk
ALAgnieszka Los-Stegienta
Agnieszka Los-Stegienta
Jolanta Słowikowska-HilczerJolanta Słowikowska-Hilczer
Jolanta Słowikowska-Hilczer
JGJerzy Gebicki
Jerzy Gebicki
This review summarizes studies dedicated to the assessment of microvascular function based on microcirculatory oscillations monitored by the Flow-Mediated Skin Fluorescence (FMSF) technique. Two approaches are presented. The first approach uses oscillatory parameters measured under normoxic conditions, expressed as flowmotion (FM), vasomotion (VM), and the normoxia oscillatory index (NOI). These parameters have been used for the identification of impaired microcirculatory oscillations associated with intense physical exercise, post-COVID syndrome, psychological stress, and erectile dysfunction. The second approach involves characterization of the microcirculatory response to hypoxia based on the measurement of hypoxia sensitivity (HS). The HS parameter is used to characterize microvascular complications in diabetes, such as diabetic kidney disease and diabetic foot ulcers. Based on research conducted by the authors of this review, the FMSF parameter ranges characterizing microvascular function are presented. The diagnostic approach to assessing microvascular function based on flowmotion monitored by the FMSF technique has a wide range of applications and the potential to be integrated into widespread medical practice.

29 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
AMAndrzej Marcinek
Andrzej Marcinek
JKJoanna Beata Katarzyńska
Joanna Beata Katarzyńska
KCKatarzyna Cypryk
Katarzyna Cypryk
ALAgnieszka Los-Stegienta
Agnieszka Los-Stegienta
Jolanta Słowikowska-HilczerJolanta Słowikowska-Hilczer
Jolanta Słowikowska-Hilczer
JGJerzy Gebicki
Jerzy Gebicki
This review summarizes studies dedicated to the assessment of microvascular function based on microcirculatory oscillations monitored by the FMSF technique. Two approaches are presented. The first approach uses oscillatory parameters measured under normoxia conditions, expressed as flowmotion (FM), vasomotion (VM), and the normoxia oscillatory index (NOI). These parameters have been used for identification of impaired microcirculatory oscillations associated with intense physical exercise, post-COVID syndrome, psychological stress, and erectile dysfunction. The second approach involves characterization of the microcirculatory response to hypoxia based on the measurement of hypoxia sensitivity (HS). The HS parameter is used to characterize microvascular complications in diabetes, such as diabetic kidney disease and diabetic foot ulcers. Based on research conducted by the authors of this review, the FMSF parameter ranges characterizing microvascular function are presented. The diagnostic approach to assessing microvascular function based on flowmotion monitored by the FMSF technique has a wide range of applications and potential to be integrated into widespread medical practice.

27 November 2018 in Clinical Diabetology
Verified
Journal Article
Open access
PDF file
ALAgnieszka Los-Stegienta
Agnieszka Los-Stegienta
JWJoanna Wójcik-Odyniec
Joanna Wójcik-Odyniec
ASAnna Sobol-Pacyniak
Anna Sobol-Pacyniak
KCKatarzyna Cypryk
Katarzyna Cypryk
Introduction. Diabetic ketoacidosis (DKA) is an acute complication of any type of diabetes, but most commonly is associated with type 1 diabetes mellitus (T1D). This condition is a complex metabolic disorder resulting from significant relative or absolute deficiency of insulin, which still leads to excess of mortality and health care burden. The main aim of the study was to assess the direct cause of DKA and to determine population at-risk among patients with greater predisposition to develop DKA, in order to propose methods and range of their education in the future. Materials and methods. This study presents a retrospective analysis of 120 cases of DKA (102 adults with diabetes) hospitalized in the Department of Internal Medicine and Diabetology at the Central Teaching Hospital of Medical University of Lodz between 2014 and 2017. Results. 68.4% of patients with DKA were T1D and LADA, 15.0% were T2D, 5.8% presented other types of diabetes and 10.8% were de novo diabetes. The mean age was 40.5 ± 17.7 years, diabetes duration 11.1 ± 9.74 years, HbA1c was 11.8 ± 2.54%. The main reason for hospitalization of patients for DKA was alcohol abuse (32.5%),followed by infection (23.4%), discontinuation of insulin treatment due to other reasons (13.4%), de novo diabetes (10.8%), lack of compliance (5.8%), mental disorders (5.8%) and complex causes (3.3%). In 5.0% of patients the reason could not be determined. All patients recovered, there was no death resulting of DKA. Conclusions. DKA occurs most frequently in T1D, but may be associated with type 2 or other types of diabetes. Most of our patients had a history of longterm poor control of diabetes. In many cases DKA, e.g. resulting from alcohol abuse or lack of compliance, probably can be avoided when proper patient education was given. Introduction. Diabetic ketoacidosis (DKA) is an acute complication of any type of diabetes, but most commonly is associated with type 1 diabetes mellitus (T1D). This condition is a complex metabolic disorder resulting from significant relative or absolute deficiency of insulin, which still leads to excess of mortality and health care burden. The main aim of the study was to assess the direct cause of DKA and to determine population at-risk among patients with greater predisposition to develop DKA, in order to propose methods and range of their education in the future. Materials and methods. This study presents a retrospective analysis of 120 cases of DKA (102 adults with diabetes) hospitalized in the Department of Internal Medicine and Diabetology at the Central Teaching Hospital of Medical University of Lodz between 2014 and 2017. Results. 68.4% of patients with DKA were T1D and LADA, 15.0% were T2D, 5.8% presented other types of diabetes and 10.8% were de novo diabetes. The mean age was 40.5 ± 17.7 years, diabetes duration 11.1 ± 9.74 years, HbA1c was 11.8 ± 2.54%. The main reason for hospitalization of patients for DKA was alcohol abuse (32.5%),followed by infection (23.4%), discontinuation of insulin treatment due to other reasons (13.4%), de novo diabetes (10.8%), lack of compliance (5.8%), mental disorders (5.8%) and complex causes (3.3%). In 5.0% of patients the reason could not be determined. All patients recovered, there was no death resulting of DKA. Conclusions. DKA occurs most frequently in T1D, but may be associated with type 2 or other types of diabetes. Most of our patients had a history of longterm poor control of diabetes. In many cases DKA, e.g. resulting from alcohol abuse or lack of compliance, probably can be avoided when proper patient education was given.